You are here

For the media

Contact Caroline Marin at 612-624-5680 or at to request an interview with an expert from any one of our health sciences programs. She will work with our entire public relations team to ensure your request is handled immediately.

New method improves accuracy of microbiome measurement

Monday, July 25, 2016

Research from the University of Minnesota Genomics Center limits biases, expands accuracy

An improved method for measuring the microbiome could lead to more clear and accurate results, providing better data for a rapidly expanding research area.

Researchers at the University of Minnesota Genomics Center assessed commonly used DNA-sequencing-based measurement methods for microbiome science. They identified a number of factors contributing to errors and biases potentially leading to irreproducible results or erroneous conclusions. Understanding how biases arise in the data allowed the researchers to design a method that minimizes amplification bias and improves accuracy.

The research is published online in the journal Nature Biotechnology.

University of Minnesota’s CIDRAP tackles the global public health issue of antimicrobial resistance

Monday, July 25, 2016

The University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP) is tackling antimicrobial resistance, one of the world’s biggest public health issues, through a new program called the Antimicrobial Stewardship Project (ASP). The ASP will help address this issue by providing current, free, accurate and comprehensive information and educational resources on antimicrobial stewardship practice, research and policy.

University of Minnesota study: Meningitis B vaccine study raises questions about vaccine response in recent New Jersey university outbreak

Wednesday, July 20, 2016

Media note: Watch Nicole Basta, Ph.D., discuss her study findings here

A new study from the University of Minnesota’s School of Public Health finds only 66 percent of college students who received the recommended two doses of the meningococcal group B vaccine Bexsero® (4CMenB) had evidence of a detectable immune response against an outbreak strain. The study was conducted during an ongoing outbreak at a New Jersey university in 2014. While no cases of meningitis B were reported among the vaccinated students during the outbreak and all vaccinees had evidence they had developed some immunity, the findings suggest the vaccine may have limited impact on certain strains.

The study findings were published online today in the New England Journal of Medicine.

University of Minnesota professor sends bone cells experiment to International Space Station

Monday, July 18, 2016

A University of Minnesota researcher is part of an out-of-this-world experiment that launched bone cells aboard SpaceX-9 earlier this morning to the International Space Station (ISS). The experiment will test the accuracy of a device designed to simulate microgravity with the goal of better understanding how gravity affects bone cell function.

UMN, Minnesota cancer experts, community members partner to put an end to cancer

Wednesday, June 29, 2016

The Masonic Cancer Center and University of Minnesota Health co-host the Minnesota Cancer Moonshot Summit today, supporting Vice President Joe Biden’s Cancer Moonshot Summit in Washington, D.C.

The Minnesota summit will be the first time in history that dozens of community partners, state legislators, research collaborators, and clinical colleagues, including the American Cancer Society, Mayo Clinic and The Hormel Institute, will convene under one roof to work toward the same goal: to achieve a decade’s worth of cancer research and treatment advances in half the time.